Mazor Robotics Ads (MZOR) 21.86 $MZOR
South Carolina HCA Affiliate, Grand Strand Medical Center, is First in the Region with a Mazor Robotics Renaissance(R) Spine Program
GlobeNewswire - Tue Aug 30, 7:10AM CDT
Mazor Robotics Ltd. (TASE:MZOR) (NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, installed a Renaissance Guidance System at Grand Strand Medical Center in Myrtle Beach, SC on July 6, 2016 and has since completed an initial case series. Grand Strand is the second in the state of South Carolina and the ninth HCA-affiliated facility to purchase a Renaissance system. See how Renaissance works.
MZOR: 21.86 (-0.52)
Medtronic Completes $20 Million Second Tranche Investment in Mazor Robotics
BusinessWire - Mon Aug 15, 3:30AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and a leader in the field of surgical guidance systems, today announced the completion of the second tranche of the equity investment by Medtronic pursuant to a previously executed agreement between the parties. The Company issued new securities representing 3.40% percent of Mazor's issued and outstanding share capital, on a fully diluted basis, at a price per ADS $21.84, which is equal to the volume weighted average price of the ADS's for the trailing 20-day period ending on and including August 9, 2016, for an aggregate purchase price of $20 million. The triggering milestone for this second tranche investment was the July 12, 2016 unveiling by the Company of Mazor X, a transformative Surgical Assurance Platform to enhance predictability of spine surgeries for the benefit of patients and those who treat them..
MDT: 86.98 (-0.05), MZOR: 21.86 (-0.52)
Mazor Robotics (MZOR) Q2 Loss Narrower than Expected
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 8:19AM CDT
Mazor Robotics reported adjusted loss of 11 cents in the second quarter of 2016.
MASI: 59.43 (+0.29), MDT: 86.98 (-0.05), MZOR: 21.86 (-0.52), MLAB: 113.38 (+1.02)
Dr. Dennis P. Devito & Dr. Kornelis Poelstra to Host Webinar on Mazor Robotics Spine Surgery Technology Following Unveiling of Mazor X(TM)
GlobeNewswire - Thu Aug 04, 7:07AM CDT
Join Pediatric Orthopedic Surgeon Dr. Dennis P. Devito and Orthopedic Surgeon Dr. Kornelis Poelstra as they discuss experiences with Mazor Robotics technology and how it has helped improve surgical results during a live webinar later this month. Both surgeons will also examine how robotics is evolving and touch on the newest features of the Mazor X(TM) surgical system.
MZOR: 21.86 (-0.52)
Mazor Robotics Reports Second Quarter Financial Results
BusinessWire - Tue Aug 02, 3:30AM CDT
--- Conference Call Today at 8:30 AM ET (3:30PM IST) -
MZOR: 21.86 (-0.52)
Can The Uptrend Continue for Mazor Robotics (MZOR)?
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 5:28AM CDT
Investors certainly have to be happy with Mazor Robotics Ltd (MZOR) and its short term performance
MZOR: 21.86 (-0.52)
Strength Seen in Mazor Robotics (MZOR) Stock Soars 10%
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:00AM CDT
Mazor Robotics Ltd. (MZOR) was a big mover last session, as the company's shares rose nearly 10% on the day.
MZOR: 21.86 (-0.52), CRY: 15.84 (-0.11)
Dr. Ronald Lehman is first in NYC to Perform PROlat(TM) Procedure with Mazor Robotics Technology
GlobeNewswire - Tue Jun 14, 3:37AM CDT
Mazor Robotics, a developer of innovative surgical guidance systems and complementary products, today announced that Dr. Ronald Lehman was the first in New York City to perform a PROlat(TM) procedure using the Mazor Robotics Renaissance Guidance System. Dr. Lehman used the technology to assist in a lateral procedure and found significant savings in both operating room time and use of fluoroscopy.
MZOR: 21.86 (-0.52)
Mazor Robotics Set to Join Russell Global Index
BusinessWire - Mon Jun 13, 3:30AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a leading developer of innovative bone mounted surgical robotic guidance systems, is set to join the Russell Global Index at the conclusion of the Russell U.S. Indexes and Russell Global Indexes annual reconstitution, effective after the U.S. market opens on June 27, 2016, according to a preliminary list of additions posted June 10, 2016.
MZOR: 21.86 (-0.52)
Mazor Robotics Receives Purchase Order from Aventura Hospital and Medical Center in Miami-Dade County
BusinessWire - Thu May 26, 3:30AM CDT
Mazor Robotics Ltd. (TASE:MZOR) (NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, announced today another Renaissance Guidance System purchase from an HCA Healthcare affiliate hospital, Aventura Hospital and Medical Center. Aventura Hospital is the seventh HCA facility to purchase a Renaissance system and the third hospital in Miami-Dade County to receive a system in the past six months.
MZOR: 21.86 (-0.52)
Mazor Robotics Signs Strategic Commercial and Investment Agreements With Medtronic, a Global Leader in Spine Technologies and Solutions
BusinessWire - Wed May 18, 3:00AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a leading developer of innovative bone mounted surgical robotic guidance systems, today entered into two strategic agreements with Medtronic plc (NYSE: MDT). One agreement is a two-stage, multi-faceted, commercial agreement for co-promotion, co-development and, upon meeting certain milestones, potential global distribution of certain Mazor products. The second agreement is for an equity investment by Medtronic in Mazor.
MDT: 86.98 (-0.05), MZOR: 21.86 (-0.52)
Mazor Robotics Reports First Quarter Financial Results
BusinessWire - Tue May 10, 3:30AM CDT
--- Conference Call Today at 8:30 AM ET (3:30PM IST) -
MZOR: 21.86 (-0.52)
Medical Robots Transforming Healthcare 2016: Pricing & Cost-Benefit Assessment Featuring Elekta, Hocoma, Intuitive Surgicals, Mazor Robotics, Rewalk & Varian Medical Systems
GlobeNewswire - Wed May 04, 4:10AM CDT
Research and Markets has announced the addition of the "Medical Robots Transforming Healthcare: Pricing & Cost-Benefit Assessment, by Product, by Application, by Geography, Reimbursement, Selection Criteria and Buying Cycle" report to their offering.
VAR: 95.89 (-0.24), MZOR: 21.86 (-0.52)
Miami HCA Affiliate, Mercy Hospital, Installs a Mazor Robotics Renaissance(R) Guidance System for Spine Surgery
BusinessWire - Wed May 04, 3:30AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a developer of innovative guidance systems and complementary products, recently installed a Renaissance Guidance System at Mercy Hospital in Miami. Mercy Hospital is the sixth HCA-affiliated facility to purchase a Renaissance system and the second hospital in Miami-Dade County to receive a system in the last six months.
MZOR: 21.86 (-0.52)
Mazor Robotics Reports First Quarter Financial Results on May 10, 2016
BusinessWire - Fri Apr 29, 3:30AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, today announced that it will report financial results for the first quarter ended March 31, 2016, before the U.S. markets open on Tuesday, May 10, 2016.
MZOR: 21.86 (-0.52)
Mazor Robotics Congratulates Baptist Medical Center Jacksonville on Surpassing 700 Procedures with Renaissance(R) Guidance System
GlobeNewswire - Thu Apr 28, 7:05AM CDT
Last week, Neurosurgeon Andrew Cannestra, MD, PhD, performed Baptist Medical Center's 700 case with the Mazor Robotics Renaissance Guidance System. The team at Baptist Medical Center Jacksonville has two Renaissance systems and uses the technology to assist in both spine and brain procedures.
MZOR: 21.86 (-0.52)
Tri-City Medical Center Performs 700 Spine Surgery Cases with Mazor Robotics Renaissance(R) Guidance System
GlobeNewswire - Wed Apr 20, 7:04AM CDT
On April 4, Dr. Payam Moazzaz performed the 700 Mazor Robotics Renaissance Spine Surgery case at Tri-City Medical Center. The Renaissancesystem uses mechanical guidance to help surgeons place pedicle screws and implants with unparalleled accuracy to correct conditions such as scoliosis and degenerative disc disease.
MZOR: 21.86 (-0.52)
Mazor Robotics: Strong Sell as Orders Register a Decline
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 12:00PM CDT
On Apr 14, Zacks Investment Research downgraded Mazor Robotics Ltd (MZOR) to a Zacks Rank #5 (Strong Sell).
VAR: 95.89 (-0.24), GMED: 23.46 (+0.23), INGN: 57.95 (-0.07), MZOR: 21.86 (-0.52)
Mazor Robotics to Present at 15th Annual Needham Healthcare Conference
BusinessWire - Tue Apr 12, 3:30AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a developer of innovative guidance systems and complementary products, today announced that Sharon Levita, Chief Financial Officer, is scheduled to present at the 15th Annual Needham Healthcare Conference on Wednesday, April 13, 2016 at 10:00am ET at the Westin Grand Central Hotel in New York City.
MZOR: 21.86 (-0.52)
Mazor Robotics Receives 5 Orders in Q1, Shares Down
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 12:20PM CDT
Shares of Mazor Robotics Ltd. (MZOR) fell 4.1% to close at $11.60 on Apr 5, after the company announced the receipt of five orders for Renaissance system.
GMED: 23.46 (+0.23), MZOR: 21.86 (-0.52), ARAY: 5.30 (-0.03), ANGO: 16.58 (+0.04)
South Carolina HCA Affiliate, Grand Strand Medical Center, is First in the Region with a Mazor Robotics Renaissance(R) Spine Program
GlobeNewswire - Tue Aug 30, 7:10AM CDT
Mazor Robotics Ltd. (TASE:MZOR) (NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, installed a Renaissance Guidance System at Grand Strand Medical Center in Myrtle Beach, SC on July 6, 2016 and has since completed an initial case series. Grand Strand is the second in the state of South Carolina and the ninth HCA-affiliated facility to purchase a Renaissance system. See how Renaissance works.
MZOR: 21.86 (-0.52)
Medtronic Completes $20 Million Second Tranche Investment in Mazor Robotics
BusinessWire - Mon Aug 15, 3:30AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and a leader in the field of surgical guidance systems, today announced the completion of the second tranche of the equity investment by Medtronic pursuant to a previously executed agreement between the parties. The Company issued new securities representing 3.40% percent of Mazor's issued and outstanding share capital, on a fully diluted basis, at a price per ADS $21.84, which is equal to the volume weighted average price of the ADS's for the trailing 20-day period ending on and including August 9, 2016, for an aggregate purchase price of $20 million. The triggering milestone for this second tranche investment was the July 12, 2016 unveiling by the Company of Mazor X, a transformative Surgical Assurance Platform to enhance predictability of spine surgeries for the benefit of patients and those who treat them..
MDT: 86.98 (-0.05), MZOR: 21.86 (-0.52)
Mazor Robotics (MZOR) Q2 Loss Narrower than Expected
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 8:19AM CDT
Mazor Robotics reported adjusted loss of 11 cents in the second quarter of 2016.
MASI: 59.43 (+0.29), MDT: 86.98 (-0.05), MZOR: 21.86 (-0.52), MLAB: 113.38 (+1.02)
Dr. Dennis P. Devito & Dr. Kornelis Poelstra to Host Webinar on Mazor Robotics Spine Surgery Technology Following Unveiling of Mazor X(TM)
GlobeNewswire - Thu Aug 04, 7:07AM CDT
Join Pediatric Orthopedic Surgeon Dr. Dennis P. Devito and Orthopedic Surgeon Dr. Kornelis Poelstra as they discuss experiences with Mazor Robotics technology and how it has helped improve surgical results during a live webinar later this month. Both surgeons will also examine how robotics is evolving and touch on the newest features of the Mazor X(TM) surgical system.
MZOR: 21.86 (-0.52)
Mazor Robotics Reports Second Quarter Financial Results
BusinessWire - Tue Aug 02, 3:30AM CDT
--- Conference Call Today at 8:30 AM ET (3:30PM IST) -
MZOR: 21.86 (-0.52)
Can The Uptrend Continue for Mazor Robotics (MZOR)?
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 5:28AM CDT
Investors certainly have to be happy with Mazor Robotics Ltd (MZOR) and its short term performance
MZOR: 21.86 (-0.52)
Strength Seen in Mazor Robotics (MZOR) Stock Soars 10%
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:00AM CDT
Mazor Robotics Ltd. (MZOR) was a big mover last session, as the company's shares rose nearly 10% on the day.
MZOR: 21.86 (-0.52), CRY: 15.84 (-0.11)
Dr. Ronald Lehman is first in NYC to Perform PROlat(TM) Procedure with Mazor Robotics Technology
GlobeNewswire - Tue Jun 14, 3:37AM CDT
Mazor Robotics, a developer of innovative surgical guidance systems and complementary products, today announced that Dr. Ronald Lehman was the first in New York City to perform a PROlat(TM) procedure using the Mazor Robotics Renaissance Guidance System. Dr. Lehman used the technology to assist in a lateral procedure and found significant savings in both operating room time and use of fluoroscopy.
MZOR: 21.86 (-0.52)
Mazor Robotics Set to Join Russell Global Index
BusinessWire - Mon Jun 13, 3:30AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a leading developer of innovative bone mounted surgical robotic guidance systems, is set to join the Russell Global Index at the conclusion of the Russell U.S. Indexes and Russell Global Indexes annual reconstitution, effective after the U.S. market opens on June 27, 2016, according to a preliminary list of additions posted June 10, 2016.
MZOR: 21.86 (-0.52)
Mazor Robotics Receives Purchase Order from Aventura Hospital and Medical Center in Miami-Dade County
BusinessWire - Thu May 26, 3:30AM CDT
Mazor Robotics Ltd. (TASE:MZOR) (NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, announced today another Renaissance Guidance System purchase from an HCA Healthcare affiliate hospital, Aventura Hospital and Medical Center. Aventura Hospital is the seventh HCA facility to purchase a Renaissance system and the third hospital in Miami-Dade County to receive a system in the past six months.
MZOR: 21.86 (-0.52)
Mazor Robotics Signs Strategic Commercial and Investment Agreements With Medtronic, a Global Leader in Spine Technologies and Solutions
BusinessWire - Wed May 18, 3:00AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a leading developer of innovative bone mounted surgical robotic guidance systems, today entered into two strategic agreements with Medtronic plc (NYSE: MDT). One agreement is a two-stage, multi-faceted, commercial agreement for co-promotion, co-development and, upon meeting certain milestones, potential global distribution of certain Mazor products. The second agreement is for an equity investment by Medtronic in Mazor.
MDT: 86.98 (-0.05), MZOR: 21.86 (-0.52)
Mazor Robotics Reports First Quarter Financial Results
BusinessWire - Tue May 10, 3:30AM CDT
--- Conference Call Today at 8:30 AM ET (3:30PM IST) -
MZOR: 21.86 (-0.52)
Medical Robots Transforming Healthcare 2016: Pricing & Cost-Benefit Assessment Featuring Elekta, Hocoma, Intuitive Surgicals, Mazor Robotics, Rewalk & Varian Medical Systems
GlobeNewswire - Wed May 04, 4:10AM CDT
Research and Markets has announced the addition of the "Medical Robots Transforming Healthcare: Pricing & Cost-Benefit Assessment, by Product, by Application, by Geography, Reimbursement, Selection Criteria and Buying Cycle" report to their offering.
VAR: 95.89 (-0.24), MZOR: 21.86 (-0.52)
Miami HCA Affiliate, Mercy Hospital, Installs a Mazor Robotics Renaissance(R) Guidance System for Spine Surgery
BusinessWire - Wed May 04, 3:30AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a developer of innovative guidance systems and complementary products, recently installed a Renaissance Guidance System at Mercy Hospital in Miami. Mercy Hospital is the sixth HCA-affiliated facility to purchase a Renaissance system and the second hospital in Miami-Dade County to receive a system in the last six months.
MZOR: 21.86 (-0.52)
Mazor Robotics Reports First Quarter Financial Results on May 10, 2016
BusinessWire - Fri Apr 29, 3:30AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, today announced that it will report financial results for the first quarter ended March 31, 2016, before the U.S. markets open on Tuesday, May 10, 2016.
MZOR: 21.86 (-0.52)
Mazor Robotics Congratulates Baptist Medical Center Jacksonville on Surpassing 700 Procedures with Renaissance(R) Guidance System
GlobeNewswire - Thu Apr 28, 7:05AM CDT
Last week, Neurosurgeon Andrew Cannestra, MD, PhD, performed Baptist Medical Center's 700 case with the Mazor Robotics Renaissance Guidance System. The team at Baptist Medical Center Jacksonville has two Renaissance systems and uses the technology to assist in both spine and brain procedures.
MZOR: 21.86 (-0.52)
Tri-City Medical Center Performs 700 Spine Surgery Cases with Mazor Robotics Renaissance(R) Guidance System
GlobeNewswire - Wed Apr 20, 7:04AM CDT
On April 4, Dr. Payam Moazzaz performed the 700 Mazor Robotics Renaissance Spine Surgery case at Tri-City Medical Center. The Renaissancesystem uses mechanical guidance to help surgeons place pedicle screws and implants with unparalleled accuracy to correct conditions such as scoliosis and degenerative disc disease.
MZOR: 21.86 (-0.52)
Mazor Robotics: Strong Sell as Orders Register a Decline
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 12:00PM CDT
On Apr 14, Zacks Investment Research downgraded Mazor Robotics Ltd (MZOR) to a Zacks Rank #5 (Strong Sell).
VAR: 95.89 (-0.24), GMED: 23.46 (+0.23), INGN: 57.95 (-0.07), MZOR: 21.86 (-0.52)
Mazor Robotics to Present at 15th Annual Needham Healthcare Conference
BusinessWire - Tue Apr 12, 3:30AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a developer of innovative guidance systems and complementary products, today announced that Sharon Levita, Chief Financial Officer, is scheduled to present at the 15th Annual Needham Healthcare Conference on Wednesday, April 13, 2016 at 10:00am ET at the Westin Grand Central Hotel in New York City.
MZOR: 21.86 (-0.52)
Mazor Robotics Receives 5 Orders in Q1, Shares Down
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 12:20PM CDT
Shares of Mazor Robotics Ltd. (MZOR) fell 4.1% to close at $11.60 on Apr 5, after the company announced the receipt of five orders for Renaissance system.
GMED: 23.46 (+0.23), MZOR: 21.86 (-0.52), ARAY: 5.30 (-0.03), ANGO: 16.58 (+0.04)
